Detailed information for compound 73776

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 679.884 | Formula: C43H53NO6
  • H donors: 3 H acceptors: 5 LogP: 7.55 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC(=O)/C=C(/C=C/[C@]1(C)[C@@H](O)CC[C@]2([C@H]1CCC1[C@]2(C)c2n3[C@@H](C(=C)C)C(=O)c4c3c(c2C1)cc1c4[C@@H](O)C2C1=CC(OC2(C)C)(C)C)C)\C
  • InChi: 1S/C43H53NO6/c1-21(2)34-37(49)32-31-24(27-20-39(4,5)50-40(6,7)33(27)36(31)48)19-25-26-18-23-11-12-28-41(8,15-13-22(3)17-30(46)47)29(45)14-16-42(28,9)43(23,10)38(26)44(34)35(25)32/h13,15,17,19-20,23,28-29,33-34,36,45,48H,1,11-12,14,16,18H2,2-10H3,(H,46,47)/b15-13+,22-17+/t23?,28-,29-,33?,34-,36+,41-,42-,43+/m0/s1
  • InChiKey: WNDPKXCADIELCH-OQGDCWBDSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus ubiquitin carboxyl terminal hydrolase BAP1 0.0313 0.3034 0.3034
Toxoplasma gondii ubiquitin carboxyl-terminal hydrolase UCHL3 0.0956 1 1
Toxoplasma gondii ubiquitin carboxyl-terminal hydrolase, family 1 protein 0.0313 0.3034 0.3034
Loa Loa (eye worm) hypothetical protein 0.0195 0.1753 0.1753
Schistosoma mansoni ubiquitinyl hydrolase-BAP1 (C12 family) 0.0313 0.3034 0.2638
Loa Loa (eye worm) hypothetical protein 0.0956 1 1
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0313 0.3034 0.3034
Entamoeba histolytica hypothetical protein 0.0313 0.3034 0.5
Schistosoma mansoni family C12 unassigned peptidase (C12 family) 0.0956 1 1
Entamoeba histolytica ubiquitin carboxyl-terminal hydrolase, putative 0.0313 0.3034 0.5
Schistosoma mansoni voltage-gated potassium channel 0.0195 0.1753 0.1284
Trichomonas vaginalis Clan CA, family C12, ubiquitin hydrolase-like cysteine peptidase 0.0956 1 0.5
Schistosoma mansoni ubiquitinyl hydrolase-UCH37 (C12 family) 0.0313 0.3034 0.2638
Echinococcus multilocularis potassium voltage gated channel protein 0.0195 0.1753 0.1284
Loa Loa (eye worm) hypothetical protein 0.0083 0.0538 0.0538
Echinococcus multilocularis ubiquitin carboxyl terminal hydrolase BAP1 0.0313 0.3034 0.2638
Echinococcus granulosus potassium voltage gated channel protein 0.0195 0.1753 0.1753
Echinococcus granulosus voltage dependent L type calcium channel subunit|voltage dependent calcium channel 0.0083 0.0538 0.0538
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel|voltage dependent L type calcium channel subu 0.0083 0.0538 0.0538
Plasmodium vivax ubiquitin carboxyl-terminal hydrolase isozyme L3, putative 0.0956 1 1
Echinococcus granulosus voltage dependent calcium channel 0.0083 0.0538 0.0538
Schistosoma mansoni voltage-gated potassium channel 0.0195 0.1753 0.1284
Echinococcus multilocularis ubiquitin carboxyl terminal hydrolase isozyme 0.0313 0.3034 0.2638
Loa Loa (eye worm) calcium channel 0.0083 0.0538 0.0538
Loa Loa (eye worm) ubiquitin C-terminal hydrolase UCH-L5 0.0313 0.3034 0.3034
Plasmodium falciparum ubiquitin carboxyl-terminal hydrolase isozyme L3 0.0956 1 1
Echinococcus granulosus ubiquitin carboxyl terminal hydrolase isozyme 0.0956 1 1
Schistosoma mansoni ubiquitinyl hydrolase-UCH37 (C12 family) 0.0313 0.3034 0.2638
Echinococcus granulosus potassium voltage gated channel subfamily A 0.0195 0.1753 0.1753
Trichomonas vaginalis Clan CA, family C12, ubiquitin hydrolase-like cysteine peptidase 0.0956 1 0.5
Echinococcus granulosus ubiquitin carboxyl terminal hydrolase isozyme 0.0313 0.3034 0.3034
Schistosoma mansoni family C12 unassigned peptidase (C12 family) 0.0956 1 1
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0956 1 1
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0313 0.3034 0.3034
Echinococcus multilocularis ubiquitin carboxyl terminal hydrolase isozyme 0.0956 1 1
Trypanosoma brucei ubiquitin carboxyl-terminal hydrolase, putative 0.0313 0.3034 0.3034
Brugia malayi Voltage-gated potassium channel, Shaker-family (KCNA, Kv1-like) alpha-subunit 0.0195 0.1753 0.1284
Echinococcus multilocularis ubiquitin carboxyl terminal hydrolase isozyme 0.0313 0.3034 0.2638
Brugia malayi ubiquitin C-terminal hydrolase UCH-L5 0.0313 0.3034 0.2638
Trypanosoma brucei ubiquitin carboxyl-terminal hydrolase, putative 0.0956 1 1
Echinococcus multilocularis potassium voltage gated channel subfamily A 0.0187 0.1662 0.1188
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel alpha 1 0.0083 0.0538 0.0538
Schistosoma mansoni family C12 unassigned peptidase (C12 family) 0.0956 1 1
Leishmania major ubiquitin carboxyl-terminal hydrolase, putative,cysteine peptidase, Clan CA, family C12, putative 0.0956 1 1

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) ~ 10 p.p.m. In vitro systemic flea efficacy using membrane feeding assay. ChEMBL. 12067553

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.